HALO
Halozyme Therapeutics, Inc.
$77.54
+1.72 (+2.27%)
At close · Jul 16
Market Cap
$9.20B
Shares
118,613,000
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.
Key facts
CIK
1159036
CUSIP
40637H109
13F (30d)
78 filings
73 filers
Visit website
Investor relations